CompletedNCT02973971

ADDIA Chronobiological Study

Studying Early-onset autosomal dominant Alzheimer disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Amoneta Diagnostics SAS
Principal Investigator
Frédéric Blanc, MD
Hôpitaux Strasbourg
Intervention
volumeric MRI(other)
Enrollment
24 target
Eligibility
55-85 years · All sexes
Timeline
20162018

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02973971 on ClinicalTrials.gov

Other trials for Early-onset autosomal dominant Alzheimer disease

Additional recruiting or active studies for the same condition.

See all trials for Early-onset autosomal dominant Alzheimer disease

← Back to all trials